-
EU tries to rally help for unpopular AstraZeneca shot
French President Emmanuel Macron (L) takes photos with his smartphone from a document from German Chancellor Angela Merkel (R) during an EU summit in Brussels on July 20, 2020. JOHN THYS | AFP | Getty Images LONDON – European officials are coming under increasing pressure to lift restrictions on who can receive the AstraZeneca-Oxford coronavirus…
-
CDC director “actually involved” about states withdrawing Covid measures as instances seem to plateau
Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention. Chip Somodevilla | Getty Images The head of the Centers for Disease Control and Prevention said Monday that she is “really concerned” that some states are pulling back public health measures to contain the coronavirus pandemic, as the US cases appear to be…
-
Novavax expects FDA approval in Might
The Food and Drug Administration could approve Novavax’s Covid-19 vaccine for emergencies as early as May, the company’s CEO Stanley Erck told CNBC on Monday. Novavax’s Phase 3 trial in the US with 30,000 participants is ongoing, Erck said. The company hopes the FDA will allow it to use data from its UK clinical trial…
-
Dr. Scott Gottlieb says knowledge exhibits Covid vaccines cut back transmission
Dr. Scott Gottlieb said Monday he saw promising signs that Covid vaccines, in addition to their well-documented ability to protect against serious illness, are effective in reducing the spread of the virus from person to person. In an interview on CNBC’s “Squawk Box,” the former Food and Drug Administration commissioner warned that while the early…
-
Diagrams present how vaccines work
Pharmacist Murtaza Abdulkarim (L) administers a dose of the AstraZeneca / Oxford Covid-19 vaccine to a patient at the Al-Abbas Islamic Center in Birmingham, West Midlands on February 4, 2021 at a temporary vaccination center manned by pharmacists and pharmacist assistants. Oli Scarff | AFP | Getty Images LONDON – The first real data from…
-
The CDC panel recommends utilizing J & J.’s single Covid vaccine.
Illustration of the Johnson & Johnson coronavirus vaccine Given Ruvic | Reuters An advisory panel to the Centers for Disease Control and Prevention unanimously voted on Sunday to recommend the use of Johnson & Johnson’s one-off Covid-19 vaccine for those ages 18 and older as the federal government prepares to serve millions of doses this…
-
Well being professionals are deeply involved
A passenger wearing a face mask shows an employee her passport and boarding pass at a security checkpoint at El Dorado International Airport in Bogota on September 1, 2020. DANIEL MUNOZ | AFP | Getty Images LONDON – Public health officials and civil liberties organizations are calling on policymakers to oppose calls for coronavirus vaccine…
-
Biden Covid workforce holds a press convention as every day U.S. circumstances regularly ease off
[The stream is slated to start at 11:00 a.m. ET. Please refresh the page if you do not see a player above at that time.] President Joe Biden’s Covid-19 Response Team plans to hold a press conference on Friday at which officials will announce a new partnership with top corporate groups to help with the…
-
CDC director warns the decline in Covid circumstances could have stalled as a result of unfold of variants
Dr. Rochelle Walensky, selected as director of the Centers for Disease Control and Prevention, speaks during an event at the Queen Theater in Wilmington, Del., Tuesday, December 8, 2020. Susan Walsh | AP The decline in Covid-19 cases reported in the US since early January could level off, a worrying shift as highly communicable variants…
-
The FDA panel unanimously recommends emergency use
A key advisory body to the Food and Drug Administration unanimously endorsed Johnson & Johnson’s emergency single-shot coronavirus vaccine on Friday. This is a critical step that paves the way for a third preventive treatment to be distributed in the US next week. The non-binding decision, made 22-0 by the FDA’s Advisory Committee on Vaccines…
